Lexaria Bioscience

LEXXNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.709 M

$5.27 -1.31%

Close of 7 Aug 2026

Revenue

$705.9K

#3527 by revenue

Earnings

-$11.9M

Loss-making

Shares outstanding

24,787,446

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#433Lisata TherapeuticsLSTA$9.65M
#434Quoin PharmaceuticalsQNRX$9.62M
#435Lexaria BioscienceLEXX$8.71M
#436ExicureXCUR$8.57M
#437Processa PharmaceuticalsPCSA$8.55M

Where these numbers come from

Share counts and financials for Lexaria Bioscience are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.